PathAI

PathAI uses AI-powered digital pathology to analyze tissue slides, quantify biomarkers, and support disease diagnosis, clinical research, and drug development for healthcare professionals.

At a Glance

Pricing Paid

PathAI is a healthcare technology company that develops AI-powered solutions for digital pathology, clinical research, and drug development. Its technology analyzes digitized tissue slides to help pathologists identify tissue patterns, measure biomarkers, and assess areas of interest. PathAI offers products such as AISight, a digital pathology image management system, and AISight Dx, an FDA-cleared platform for primary diagnosis within its specified use. It also provides AI tools that help pharmaceutical companies analyze tissue samples during clinical trials. PathAI supports pathologists and researchers rather than replacing professional medical judgment.

How PathAI Works

PathAI combines digital slide imaging and AI models to analyze tissue samples. The process varies by product and intended use.

  • Slide Digitization: A laboratory scans tissue samples using a compatible whole-slide scanner and uploads the digital images to its pathology system.
  • Tissue Analysis: AI models identify areas of interest and analyze tissue structures, cellular patterns, and potential tumor regions.
  • Biomarker Measurement: Supported tools quantify cells and biomarkers, such as HER2, ER, PR, Ki-67, and PD-L1, for specific applications.
  • Professional Review: Pathologists or researchers review the AI-generated findings and use them to support diagnostic or research workflows.
  • Reporting: Results can be incorporated into supported laboratory workflows or clinical research assessments.

How We Rated PathAI

We assessed PathAI based on its published features, digital pathology capabilities, biomarker analysis, research applications, integration options, regulatory milestones, and pricing transparency. This is a feature-based review of available information, not an independent hands-on test.

Pros

  • Helps analyze digital tissue slides and biomarkers.
  • Automates selected image analysis tasks.
  • Supports digital case management and collaboration.
  • Offers tools for pharmaceutical research and clinical trials.
  • Includes an FDA-cleared platform for specified clinical use.
  • Integrates with supported scanners and laboratory systems.

Cons

  • Pricing is not publicly listed as a fixed subscription.
  • Digital pathology may require specialized scanners and storage.
  • Laboratory system integration can require technical resources.
  • Results depend on image quality and the specific AI application.
  • Clinical use must follow applicable regulatory requirements.
  • Not every research tool is cleared for routine diagnosis.

  • Pathology laboratories
  • Hospitals
  • Pharmaceutical companies
  • Clinical research organizations
  • Academic institutions
  • Biotechnology companies

PathAI combines digital slide management with AI-powered tissue analysis and biomarker measurement. This can help laboratories reduce repetitive manual work and support more consistent assessments.

Its tools also support pharmaceutical research and clinical trials. However, organizations should check each product's intended use, regulatory status, scanner compatibility, and validation evidence before adopting it.

PathAI's Key Features

AI-powered digital pathology analysis

AISight image and case management

AISight Dx for cleared clinical use

Tumor detection and tissue segmentation

Cell counting and biomarker quantification

AI tools for clinical trials and drug development

Digital slide viewing and collaboration

Integration with supported scanners and laboratory systems

Pricing

Free Plan

Free

Disclaimer: for the latest and most accurate pricing, please visit the official PathAI website.

Frequently Asked Questions

How does PathAI use artificial intelligence in pathology?
PathAI uses deep learning to analyze digitized tissue slides, identify areas of interest, assess cellular structures, and quantify biomarkers. Its findings support pathologists and researchers.
What types of diseases can PathAI's technology help researchers study?
PathAI supports research in areas including cancer and metabolic dysfunction-associated steatohepatitis (MASH). Available applications depend on the specific tool.
Can PathAI integrate with existing laboratory workflows?
Yes. PathAI supports integration with compatible slide scanners and laboratory systems. Compatibility depends on the product and existing infrastructure.
How does PathAI support pharmaceutical drug development?
PathAI provides AI tools and pathology services that help pharmaceutical companies analyze tissue samples, measure biomarkers, and assess disease-related changes during clinical trials.
What types of data does PathAI analyze?
PathAI primarily analyzes digital tissue slide images. Depending on the application, it can assess cellular structures, tumor regions, and biomarker expression.
Who can benefit from PathAI's pathology solutions?
Pathology laboratories, hospitals, pharmaceutical companies, biotechnology firms, clinical research organizations, and academic institutions can use PathAI for suitable diagnostic, research, and drug development workflows.

0.0

Based on user reviews

Reviews are moderated before they appear here. Share your experience with PathAI to help others decide.

Write a review

For AI Builders

Built an AI Tool? Get It Listed.

Reach thousands of professionals actively hunting for new AI solutions every single day.